SFL director holds 12,647 shares, option grants
Director James O'Shaughnessy reports direct common share holdings and multiple vested and unvested option grants in SFL Corp Ltd.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
SFL Corp Ltd. (SFL) reported the initial beneficial ownership of director James O'Shaughnessy on a Form 3. As of September 14, 2026 he holds 12,647 common shares directly and several grants of share options over common shares with exercise prices between $4.25 and $10.28 and expirations from May 2026 through February 2031. The options vest in equal annual installments over three years under the issuer's Share Option Scheme and become exercisable upon vesting.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
O'SHAUGHNESSY JAMES
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Share options F1 | -- | -- | -- |
| Holding | Share options F2 | -- | -- | -- |
| Holding | Share options F3 | -- | -- | -- |
| Holding | Share options F4 | -- | -- | -- |
| Holding | Share options F5 | -- | -- | -- |
| Holding | Share options F6 | -- | -- | -- |
| Holding | Common Shares | -- | -- | -- |
Holdings:
Share options — 166,000 contracts (Direct);
Common Shares — 12,647 shares (Direct)
Footnotes (6)
- F1. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on May 13, 2022 and subsequent vesting on May 13, 2023 and May 13, 2024. These share options become exercisable upon vesting.
- F2. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 15, 2023 and subsequent vesting on February 15, 2024 and February 15, 2025. These share options become exercisable upon vesting.
- F3. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 14, 2024 and subsequent vesting on February 14, 2025 and February 14, 2026. These share options become exercisable upon vesting.
- F4. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 13, 2025 and subsequent vesting on February 13, 2026 and February 13, 2027. These share options become exercisable upon vesting.
- F5. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on March 12, 2026 and subsequent vesting on March 12, 2027 and March 12, 2028. These share options become exercisable upon vesting.
- F6. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 19, 2027 and subsequent vesting on February 19, 2028 and February 19, 2029. These share options become exercisable upon vesting.
Key Figures
Direct common shares held: 12,647 shares
Option exercise price: $4.25 per share
Option exercise price: $4.67 per share
+4 more
7 metrics
Direct common shares held
12,647 shares
Common shares held directly by James O'Shaughnessy as reported on Form 3
Option exercise price
$4.25 per share
Share options over 25,000 underlying common shares expiring May 13, 2026
Option exercise price
$4.67 per share
Share options over 30,000 underlying common shares expiring February 15, 2027
Option exercise price
$7.16 per share
Share options over 25,000 underlying common shares expiring February 14, 2028
Option exercise price
$9.81 per share
Share options over 25,000 underlying common shares expiring February 13, 2029
Option exercise price
$7.52 per share
Share options over 26,000 underlying common shares expiring March 12, 2030
Option exercise price
$10.28 per share
Share options over 35,000 underlying common shares expiring February 19, 2031
Key Terms
beneficial ownership, Share Option Scheme, underlying common shares, vest over a three-year period, +1 more
5 terms
beneficial ownership financial
"reported the initial beneficial ownership of director James O'Shaughnessy"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
vest over a three-year period financial
"share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year"
exercisable upon vesting financial
"These share options become exercisable upon vesting"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 3 filing reveal about SFL director James O'Shaughnessy?
It shows that James O'Shaughnessy is a director of SFL Corp Ltd. and reports his initial beneficial ownership, including 12,647 common shares held directly and several grants of share options over common shares with various exercise prices and expirations.
AI-generated analysis. How Rhea-AI works. Not financial advice.
